ATE494281T1 - Ppar-aktivierende verbindung und diese enthaltende pharmazeutische zusammensetzung - Google Patents

Ppar-aktivierende verbindung und diese enthaltende pharmazeutische zusammensetzung

Info

Publication number
ATE494281T1
ATE494281T1 AT04772699T AT04772699T ATE494281T1 AT E494281 T1 ATE494281 T1 AT E494281T1 AT 04772699 T AT04772699 T AT 04772699T AT 04772699 T AT04772699 T AT 04772699T AT E494281 T1 ATE494281 T1 AT E494281T1
Authority
AT
Austria
Prior art keywords
group
atom
hydrogen atom
ppar
pharmaceutical composition
Prior art date
Application number
AT04772699T
Other languages
English (en)
Inventor
Yukiyoshi Yamazaki
Tsutomu Toma
Masahiro Nishikawa
Hidefumi Ozawa
Ayumu Okuda
Takaaki Araki
Kazutoyo Abe
Soichi Oda
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Priority claimed from PCT/JP2004/012750 external-priority patent/WO2005023777A1/ja
Application granted granted Critical
Publication of ATE494281T1 publication Critical patent/ATE494281T1/de

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT04772699T 2003-09-03 2004-09-02 Ppar-aktivierende verbindung und diese enthaltende pharmazeutische zusammensetzung ATE494281T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49935703P 2003-09-03 2003-09-03
JP2003317353 2003-09-09
JP2003364817 2003-10-24
PCT/JP2004/012750 WO2005023777A1 (ja) 2003-09-03 2004-09-02 Ppar活性化化合物及びこれを含有する医薬組成物

Publications (1)

Publication Number Publication Date
ATE494281T1 true ATE494281T1 (de) 2011-01-15

Family

ID=43426133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04772699T ATE494281T1 (de) 2003-09-03 2004-09-02 Ppar-aktivierende verbindung und diese enthaltende pharmazeutische zusammensetzung

Country Status (6)

Country Link
AT (1) ATE494281T1 (de)
DE (1) DE602004030921D1 (de)
DK (1) DK1661890T3 (de)
MY (1) MY142063A (de)
PT (1) PT1661890E (de)
SI (1) SI1661890T1 (de)

Also Published As

Publication number Publication date
SI1661890T1 (sl) 2011-04-29
MY142063A (en) 2010-08-30
DK1661890T3 (da) 2011-03-14
DE602004030921D1 (de) 2011-02-17
PT1661890E (pt) 2011-04-04

Similar Documents

Publication Publication Date Title
HRP20110009T1 (hr) Spoj kojim se aktivira ppar i farmaceutski pripravak koji ga sadrži
AR058403A1 (es) PIRIMIDINILOXI Y PIRIDINILOXI UREAS SUSTITUíDAS COMO INHIBIDORES DE PROTEíNA QUINASAS, COMPOSICIONES FARMACÉUTICAS QUE LAS CONTIENEN Y SU USO EN LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA ACTIVIDAD BASAL DE B-RAF.
AR058362A1 (es) Derivados de isoquinolina - aminopirazol su obtencion y su utilizacion como agentes farmaceuticos
RU2008120601A (ru) Производные аминодигидротиазина
AR053554A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
UA84156C2 (ru) Фторозамещённая омега-карбоксиарилдифенилмочевина для лечения и профилактики болезней и состояний
NO20070468L (no) Sammensetninger og fremgangsmater for behandling av dyslipidemi
EP1775283A4 (de) 3-aminobenzamid-verbindung und hemmer der aktivität des vanilloid-rezeptors 1 (vr1)
UY30107A1 (es) Nuevos derivados de pirimidina, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
HRP20000406B1 (en) Arylpiperazines having activity at the serotonin 1a receptor
EP1714961A4 (de) Indazolverbindung und deren pharmazeutische verwendung
WO2004010949A3 (en) Compounds active in spinigosine 1-phosphate signaling
AR052898A1 (es) Derivados de la n-[(4,5-difenil -2-tienil) metil] amina, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para enfermedades mediadas por los receptores canabinoides cb1
DK0769010T3 (da) 2-[1',2',4'-triazol-3'-yloxymethylen]-anilider og deres anvendelse som pesticider
TW200732309A (en) Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
GEP20115222B (en) New pharmaceutical compounds
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
TW200634001A (en) Novel compounds
AR083020A1 (es) Uso de un compuesto de [3-(1-(1h-imidazol-4-il)etil)-2-metilfenil]metanol para preparar un medicamento util para tratar enfermedades y afecciones de la piel, articulo de fabricacion y composicion farmaceutica que lo comprenden
DE60024471D1 (de) Benzopyran derivate
TW200508221A (en) New azetidine compounds
SE0300092D0 (sv) Novel compounds
CA2461963A1 (en) Cyclic amine compounds
BRPI0507763A (pt) moduladores de receptor seletivo do subtipo gaba-a heterocìclicos
SV2006002238A (es) Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1661890

Country of ref document: EP